Created at 11:22 a.m. May, 02, 2025
Author: amv4012
Related Note: 1481330867563 3
Rationale for change

AMBOSS and UpToDate lists that all patients with polycythemia vera undergo phlebotomy and take low-dose aspirin

https://next.amboss.com/us/article/kT0mI2?q=polycythemia%20vera#Z86941b92e2c44caf6d6becf9171d08b2

https://www-uptodate-com.wcmq.idm.oclc.org/contents/polycythemia-vera-and-secondary-polycythemia-treatment-and-prognosis?search=polycythemia%20vera&topicRef=4517&source=see_link

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_dorian #AK_Step2_v12::#Resources_by_rotation::Neuro::ome::stroke #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::leukemia #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::02_Myeloproliferation #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::03_Polycythemia #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::31_Polycythemia::*Polycythemia_Vera #AK_Step2_v12::Original_decks::Dorian::im::uw::heme/onc #AK_Step2_v12::Original_decks::Dorian::fam::ome::neuro::stroke #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::10_Plasma_Cell_Dyscrasias_&_Myeloproliferative_Disease::03_Polycythemia_Vera_&_Essential_Thrombocythemia #AK_Step1_v12::^Other::^FA_Updates::FA2018 #PANCE::HEME::cytoses #AK_Step2_v12::#UWorld::COMLEX::28693 #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::29_Myeloproliferative_neoplasms::01_Polycythemia_vera #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::01_Myeloproliferative_Neoplasms_&_Myelodysplastic_Syndromes #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_zanki #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::03_White_Cells::02_Myeloproliferative_Disorders #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::05_Leukemia #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::HemeOnc #AK_Step1_v12::^Systems::HemeOnc::WBC #AK_Step2_v12::#AMBOSS::ZF0Zg3 #AK_Step2_v12::#UWorld::Step::2883 #AK_Step2_v12::#Resources_by_rotation::FM::ome::neuro::stroke #AK_Step2_v12::Original_decks::Dorian::neuro::ome::stroke #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::29_Myeloproliferative_neoplasms #AK_Step2_v12::#Subjects::Hematology::03_WBC::04_Myeloproliferative_Disorders::Polycythemia_Vera #AK_Step2_v12::#OME::02_Neurology::01_Stroke #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::03_Myeloproliferative_Disorders::01_Myeloproliferative_Disorders_Overview #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::leukemia #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::03_Myeloproliferative_Disorders::02_Polycythemia_Vera #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::#AMBOSS::-t0DT3 #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::^Other::^EXPN::BGedit #AK_Step2_v12::#Subjects::Hematology::02_RBC::04_Procedures::Phlebotomy #AK_Step1_v12::#Pathoma::06_WBC::04_Myeloproliferative #AK_Step1_v12::#Bootcamp::Genetics::01_DNA_Structure::05_Clinical_Applications_of_the_Pyrimidine_Pathway #AK_Step2_v12::#AMBOSS #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::14_Myeloproliferative_Disorders #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::01_Antimetabolites::01_Methotrexate,_leucovorin,_5-fluorouracil,_hydroxyurea #AK_Step1_v12::#OME::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::02_Myeloproliferation #AK_Step2_v12::#AMBOSS::zt0rT3 #AK_Step1_v12::#AMBOSS::qiaCs4